ir.ctmholdings.com
Investor Relations
On June 6, 2012, the Board of Directors of the Company approved a change in the Company s fiscal year end from July 31 to October 31 of each year. CTM Media Holdings, Inc., a Delaware corporation, is a holding company consisting of the following principal businesses:. CTM Media Group, our brochure distribution company and other advertising-based product initiatives focused on small to medium sized businesses; and. Sep 10, 2014. Oct 31, 2013. Dec 07, 2012. May 05, 2010. Feb 24, 2010. CTM Holdings, Inc.
ir.ctwater.com
Connecticut Water - Investors - Overview
Mansfield/UConn Water Supply Project. Water System Advisory Committee. Stock Quote and Chart. Quarterly and Annual Results. Minimum 20 min. delay). January 12, 2017. December 8, 2016. PURA Approves Connecticut Water’s Acquisition of Heritage Village Water Company. December 6, 2016. Connecticut Water to Host Second Annual Analyst-Investor Conference Call and Webcast on December 13, 2016. December 5, 2016. Connecticut Water Service Inc. Presentation Now Available for On-Demand Viewing. 10-K (PDF 968 KB.
ir.curtisswright.com
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
ir.cutera.com
Investor Overview - Cutera
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec aliquam, enim eget sodales pulvinar, odio dui pulvinar urna, aliquet lacinia nulla elit ut felis. If you have any questions or need further information about CUTERA’s product portfolio, please complete the form below and a CUTERA representative will be in touch within 24 business hours. Fields with ( *. Please use one of the following supported browsers to complete this form;. Microsoft Internet Explorer (v9 and v10). Fields with ( *. Cutera,...
ir.cvgrp.com
CVG Investor Relations - Investor Relations Home
0) { window.location='http:/ www.cvgrp.com/en-us/search/pages/results.aspx? K=' str; } }" type="text" maxlength="200" autocomplete="off" alt="Enter search words" style="width: 115px"/. Biomechanics and Human Factors. Design and Build of Full Cab Prototypes. Annual Reports and Proxy Statements. Directors and Executive Officers. Stock Quote and Information. CVG and Product Brand Artwork. Industry Events and Tradeshows. Annual Reports and Proxy Statements. Directors and Executive Officers. CVG Continues Mar...
ir.cwco.com
Corporate Profile | CWCO
Market Value ($M) :. Consolidated Water Co. Ltd. Second Quarter Conference Call. August 11, 2015. Consolidated Water Co. Ltd. to Host Second Quarter Conference Call on Tuesday, August 11, 2015. Consolidated Water Co. Ltd. to Participate in ROTH Capital Partners Cleantech Day on June 25, 2015 in London. TERMS AND CONDITIONS OF USE. The Site does not represent an offer or solicitation with respect to the purchase or sale of any security. These Terms of Use are the entire agreement between the parties with ...
ir.cybergypartners.com
Cybergy Holdings, Inc. (CYBG)
Cybergy Holdings, Inc. (OTCPink: CYBG). Our Services and Products. Commercial and Government Clients. Bill Gregorak Appointed New Chief Financial Officer of Cybergy Partners. Aug 5, 2015. Mar 31, 2015. Sign up for email alerts. Be the first to receive breaking news. Chairman, Cybergy Board of Directors / CEO. Mr Gray is Chairman of the Cybergy Partners Board of Directors, leading its acquisition strategy and investment committee. He has over 20 years of M&A, investment banking and financial advisory ...
ir.cyberonics.com
Investor Relations | Cyberonics
Skip to main content. An innovator in neuromodulation. Learn about Cyberonics, the creator of VNS Therapy. An innovator in neuromodulation. Discover more about Cyberonics innovation. Committed to advancing science. Apply for grants for CME credit, physician and patient educational programs, and more. Search career opportunities at Cyberonics. Table of content - -. Day High: 59.26. Day Low: 57.90. Aug 7, 2015. Delayed at least 20 min., by eSignal. View all ». Aug 6, 2015. Jul 27, 2015. View all ». Cyberon...
ir.cymabay.com
CYMABAY THERAPEUTICS
CymaBay Therapeutics (NASDAQ: CBAY). CymaBay Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough therapies addressing unmet medical needs. Arhalofenate, the company's lead product candidate, possesses two therapeutic actions in a single drug. In gout patients, arhalofenate is intended to prevent painful attacks in joints while at the same time promoting excretion of uric acid by the kidney, thereby removing the root cause of this debilitating disease. As of March 3, 2014).
ir.cyren.com
Investor Relations - CYREN
Solutions for Resellers and Distributors. Solutions for Service Providers. Solutions for Security Vendors. Mobile Security for Android. Industry Reports and White Papers. Annual Reports and Proxies. CYREN is traded on the NASDAQ Capital Market and the Tel Aviv Stock Exchange (TASE) under the trading symbol “CYRN”. NASDAQ and TASE: CYRN. 4:00 PM ET on August 14, 2015. Delayed at least 20 minutes. August 12, 2015. CYREN Announces Pricing Of Public Offering Of Ordinary Shares. August 11, 2015.
ir.cytokinetics.com
Cytokinetics - Investors & Media - Investor Overview
We’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions. We’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions. We’re advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. Cytokinetics’ unparalleled expertise has kept it at the forefront of drug d...
